^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MSK-ACCESS

    Company:
    Memorial Sloan-Kettering Cancer Center
    Type:
    Laboratory Developed Test
    Related tests:
    The MSK-ACCESS assay is a comprehensive liquid biopsy test that offers noninvasive cancer genomic profiling and disease monitoring. It involves the deep sequencing of 129 key cancer-associated genes selected from MSK’s solid tumor genomic-profiling assay. MSK-ACCESS is designed to detect genetic alterations in cfDNA (cell-free DNA) specimens, such as blood and other body fluids.
    Cancer:
    Solid Tumor
    Method:
    Liquid biopsy